Chengdu, China

Pingjin Zou


Average Co-Inventor Count = 5.5

ph-index = 1


Company Filing History:


Years Active: 2024-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Pingjin Zou in Cancer Treatment

Introduction

Pingjin Zou is a notable inventor based in Chengdu, China, recognized for his contributions to cancer treatment technologies. He holds 2 patents that focus on advanced methods for radiation therapy and photodynamic therapy.

Latest Patents

One of his latest patents is titled "Method for assembling an adjustable collimator for spatially fractionated radiation therapy." This invention discloses a method for assembling an adjustable collimator that utilizes stacked penetrating sheets to form penetration sections, which can be adjusted based on the radiation area requirements. The design allows for cost-effective applications in spatially fractionated radiation therapy.

Another significant patent is "Preparation of photodynamic therapy tablet and method for construction and application of anti-tumor model for enhanced cancer treatment." This invention features a photodynamic therapy tablet that includes a wireless power supply, a micrometer-level LED array, and a biocompatible encapsulation. It is designed for surgical implantation near tumor cells, enabling precise irradiation and effective triggering of ferroptotic cell death in tumor cells.

Career Highlights

Pingjin Zou is affiliated with Sichuan Cancer Hospital, where he applies his innovative ideas to improve cancer treatment methodologies. His work has the potential to significantly enhance the efficacy of cancer therapies.

Collaborations

He collaborates with notable colleagues, including Meihua Chen and Jinyi Lang, who contribute to his research and development efforts.

Conclusion

Pingjin Zou's innovative patents reflect his commitment to advancing cancer treatment technologies. His work in developing adjustable collimators and photodynamic therapy tablets showcases the potential for improved patient outcomes in oncology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…